The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review

Clozapine is considered the golden standard in the treatment of therapy‐resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. Current evidence suggests that the sublingual use of atropine seems to be safe and effective and could be considered as a first‐lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Van der Poorten, Thomas, De Hert, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878073/
https://www.ncbi.nlm.nih.gov/pubmed/31788260
http://dx.doi.org/10.1002/ccr3.2431
_version_ 1783473463801937920
author Van der Poorten, Thomas
De Hert, Marc
author_facet Van der Poorten, Thomas
De Hert, Marc
author_sort Van der Poorten, Thomas
collection PubMed
description Clozapine is considered the golden standard in the treatment of therapy‐resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. Current evidence suggests that the sublingual use of atropine seems to be safe and effective and could be considered as a first‐line treatment of clozapine‐induced sialorrhea.
format Online
Article
Text
id pubmed-6878073
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68780732019-11-29 The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review Van der Poorten, Thomas De Hert, Marc Clin Case Rep Case Reports Clozapine is considered the golden standard in the treatment of therapy‐resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. Current evidence suggests that the sublingual use of atropine seems to be safe and effective and could be considered as a first‐line treatment of clozapine‐induced sialorrhea. John Wiley and Sons Inc. 2019-09-27 /pmc/articles/PMC6878073/ /pubmed/31788260 http://dx.doi.org/10.1002/ccr3.2431 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Van der Poorten, Thomas
De Hert, Marc
The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
title The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
title_full The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
title_fullStr The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
title_full_unstemmed The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
title_short The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
title_sort sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: a systematic review
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878073/
https://www.ncbi.nlm.nih.gov/pubmed/31788260
http://dx.doi.org/10.1002/ccr3.2431
work_keys_str_mv AT vanderpoortenthomas thesublingualuseofatropineinthetreatmentofclozapineinducedsialorrheaasystematicreview
AT dehertmarc thesublingualuseofatropineinthetreatmentofclozapineinducedsialorrheaasystematicreview
AT vanderpoortenthomas sublingualuseofatropineinthetreatmentofclozapineinducedsialorrheaasystematicreview
AT dehertmarc sublingualuseofatropineinthetreatmentofclozapineinducedsialorrheaasystematicreview

Ejemplares similares